RU2008110083A - Ингибиторы протеинкиназы на основе алкоксииндолинонов - Google Patents

Ингибиторы протеинкиназы на основе алкоксииндолинонов Download PDF

Info

Publication number
RU2008110083A
RU2008110083A RU2008110083/04A RU2008110083A RU2008110083A RU 2008110083 A RU2008110083 A RU 2008110083A RU 2008110083/04 A RU2008110083/04 A RU 2008110083/04A RU 2008110083 A RU2008110083 A RU 2008110083A RU 2008110083 A RU2008110083 A RU 2008110083A
Authority
RU
Russia
Prior art keywords
compound
tautomer
salt
prodrug
represented
Prior art date
Application number
RU2008110083/04A
Other languages
English (en)
Russian (ru)
Inventor
Конгксин ЛИАНГ (US)
Конгксин ЛИАНГ
Янгбо ФЕНГ (US)
Янгбо ФЕНГ
Original Assignee
Зе Скрипс Ресеч Инститьют (Us)
Зе Скрипс Ресеч Инститьют
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зе Скрипс Ресеч Инститьют (Us), Зе Скрипс Ресеч Инститьют filed Critical Зе Скрипс Ресеч Инститьют (Us)
Publication of RU2008110083A publication Critical patent/RU2008110083A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
RU2008110083/04A 2005-09-22 2006-09-21 Ингибиторы протеинкиназы на основе алкоксииндолинонов RU2008110083A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71947405P 2005-09-22 2005-09-22
US60/719,474 2005-09-22

Publications (1)

Publication Number Publication Date
RU2008110083A true RU2008110083A (ru) 2009-10-27

Family

ID=37900093

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008110083/04A RU2008110083A (ru) 2005-09-22 2006-09-21 Ингибиторы протеинкиназы на основе алкоксииндолинонов

Country Status (10)

Country Link
US (2) US7629339B2 (enExample)
EP (1) EP1926725A4 (enExample)
JP (1) JP2009508971A (enExample)
KR (1) KR20080046701A (enExample)
CN (1) CN101282965A (enExample)
AU (1) AU2006294600A1 (enExample)
BR (1) BRPI0616378A2 (enExample)
CA (1) CA2621809A1 (enExample)
RU (1) RU2008110083A (enExample)
WO (1) WO2007038251A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0616378A2 (pt) * 2005-09-22 2011-06-21 Scripps Research Inst inibidores de proteìna cinase baseados em alcóxi indolinona e métodos para modulação da atividade catalìtica
EP2061758A4 (en) * 2006-09-11 2011-11-30 Curis Inc A ZINC BINDING GROUP CONTAINING SUBSTITUTED 2-INDOLINONE AS PTK INHIBITORS
WO2008033562A2 (en) 2006-09-15 2008-03-20 Xcovery, Inc. Kinase inhibitor compounds
IN2014MN02105A (enExample) 2012-04-20 2015-09-11 Annji Pharm Co Ltd
ES2714110T3 (es) 2014-03-07 2019-05-27 Hoffmann La Roche Heteroarildihidropirimidinas 6-fusionadas novedosas para el tratamiento y profilaxis de la infección por el virus de la hepatitis B
SG11201706835WA (en) 2015-03-16 2017-09-28 Hoffmann La Roche Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor
CN109715214B (zh) 2016-09-13 2022-03-04 豪夫迈·罗氏有限公司 Tlr7激动剂和hbv衣壳组装抑制剂的组合治疗
CN110016052B (zh) * 2018-01-08 2021-09-28 四川海思科制药有限公司 N-去乙基舒尼替尼的磷酰胺衍生物及其制备方法
CA3130596A1 (en) 2019-03-25 2020-10-01 F. Hoffmann-La Roche Ag Solid forms of a compound of hbv core protein allosteric modifier

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US72934A (en) * 1867-12-31 Improvement in marking-gauge fob sswim-mgohines
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
TWI259081B (en) * 2001-10-26 2006-08-01 Sugen Inc Treatment of acute myeloid leukemia with indolinone compounds
MXPA06006049A (es) * 2003-11-26 2007-05-24 Scripps Research Inst Inhibidores de proteina quinasa avanzados a base de indolinona.
BRPI0616378A2 (pt) * 2005-09-22 2011-06-21 Scripps Research Inst inibidores de proteìna cinase baseados em alcóxi indolinona e métodos para modulação da atividade catalìtica

Also Published As

Publication number Publication date
EP1926725A1 (en) 2008-06-04
EP1926725A4 (en) 2010-10-06
WO2007038251A1 (en) 2007-04-05
CA2621809A1 (en) 2007-04-05
AU2006294600A1 (en) 2007-04-05
JP2009508971A (ja) 2009-03-05
CN101282965A (zh) 2008-10-08
KR20080046701A (ko) 2008-05-27
US20070072934A1 (en) 2007-03-29
US20090305382A1 (en) 2009-12-10
BRPI0616378A2 (pt) 2011-06-21
US7629339B2 (en) 2009-12-08

Similar Documents

Publication Publication Date Title
AR059184A1 (es) Derivados de sulfonamidas, su preparacion y su aplicacion en tarapeutica
MX2021009763A (es) Derivados de 3-(1-oxo-5-(piperidin-4-il)isoindolin-2-il)piperidina -2,6-diona y usos de los mismos.
AR069804A1 (es) Agonistas del receptor glucocorticoide c20- c21 sustituido
DOP2010000213A (es) Derivados de carboxamidas azabiciclicas, su preparacion y su aplicacion en terapeutica
RU2007103815A (ru) Производное тиенопиразола, имеющее ингибирующую фосфодиэстеразу 7(pde 7) активность
AR081626A1 (es) Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
EA201170096A1 (ru) Замещенные производные пиримидона
EA200970493A1 (ru) Макроциклические ингибиторы вируса гепатита с
EA201070874A1 (ru) Производные индол-2-карбоксамидов и азаиндол-2-карбоксамидов, замещённых силанильной группой, их получение и применение в терапии
RU2011103454A (ru) Бициклические гетероциклы в качестве ингибиторов киназы мек
EA201070871A1 (ru) Бициклические производные азабициклических карбоксамидов, их получение и их применение в терапии
ATE556058T1 (de) 1-(2h)-isochinolonderivat
EA200800476A1 (ru) Макроциклические ингибиторы вируса гепатита с
AR058554A1 (es) Compuestos heterociclicos nitrogenados de 6 miembros sustituidos, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por mglur5.
CO6160296A2 (es) Derivados de acido benzoazepin-oxi-acetico como agonistas de receptores activados por proliferador de peroxisona delta usados para incrementar la lipoproteina de alta densidad-colesterol-colesterol reducir la lipoproteina de baja densidad-colesterol
RU2012116526A (ru) Способы получения производных пиримидина, применимых в качестве ингибиторов протеинкиназы
ES2653419T3 (es) Pirazolopirimidinilamino-indazoles sustituidos
CO6220970A2 (es) Compuestos heterociclicos que contienen nitrogeno y metodos de uso de los mismos
EA201070839A1 (ru) Новые производные ацилцианопирролидинов
AR076098A1 (es) Derivados de benzofurano
EA201070891A1 (ru) Замещенные гетероариламидные производные диазепинопиримидона
EA200971061A1 (ru) Пиримидоновые соединения гетероариламидов
EA201100368A1 (ru) Амидные соединения, полезные в терапии
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
MX2021008252A (es) Compuesto de pirimidina o sal del mismo.

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20110112